Journal of Neuroscience · 1992 · 117 citations · 33 references
Life SciencesNeurosciencePharmacologyNeurochemistryNeuropharmacologyPharmacodynamicsAmino Acid NeurochemistryNeuromodulationNeuropeptide PharmacologyNeurotoxic MechanismsNeurotransmissionOpioid PharmacologyAmino AcidsDynorphin ModulationEndogenous OpioidsNon-opioid AnalgesiaOpioid Peptide PharmacologyOpioid PharmacodynamicsOpioid Receptor Binding
Administration of dynorphin A-(1-17) (Dyn 1-17), through a microdialysis probe stereotaxically placed into rat hippocampus, caused marked increases in the extracellular levels of glutamate and aspartate. The degree and duration of elevation of these excitatory amino acids (EAA) induced by Dyn 1-17 were dose dependent but were not modified by the centrally active opioid receptor antagonist nalmefene. At comparable doses, Dyn 2-17, which is inactive at the opioid receptor, produced similar alterations in EAA as Dyn 1-17, whereas Dyn 1-8 caused significantly smaller changes of glutamate. Dynorphin and EAAs have each been implicated as pathophysiological factors in brain or spinal cord injuries, with dynorphin's actions shown to involve both opioid and non-opioid components. The present observations indicate a direct potential linkage between dynorphin and excitotoxin mechanisms of CNS injury and provide further support for the concept that dynorphin's pathophysiologic effects may include non-opioid actions of this peptide.
33
Helene Benveniste, Jørgen Drejer, Arne Schousboe et al. · Journal of Neurochemistry · 1984 · 2.9K citations
The Role of Excitatory Amino Acids and NMDA Receptors in Traumatic Brain Injury
Alan I. Faden, Paul Demediuk, S. Scott Panter et al. · Science · 1989 · 1.5K citations